ZURICH/BERLIN, Aug 18(Reuters) - Here are some of the main
factors that may affect Swiss stocks on Tuesday:
NOVARTIS NOVN.S
A U.S. district court upheld the validity of a patent for
Swiss drugmaker Novartis' NOVN.S top-selling multiple
sclerosis (MS) drug Gilenya, helping Novartis protect its
blockbuster MS treatment from U.S. competition. urn:newsml:reuters.com:*:nL8N2FJ4Q8
GEBERIT GEBN.S
Half-year results due.
COMPANY STATEMENTS
* Zur Rose Group ROSEG.S said it successfully concluded
the acquisition of the e-commerce and diabetes activities of
Apotal Group. ROSEG.S
* Schlatter Industries AG STRN.S reported an operating
loss (EBIT) OF -3.6 million Sfr in the first half of the year.
urn:newsml:reuters.com:*:nFWN2FJ0YG
ECONOMY
No major economic data scheduled.
(Reporting by Zurich newsroom and Berlin Speed Desk)
((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
((For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g
FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES
Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH
All equity news E
SPEED GUIDES: EQUITY EQUITY/NEWS1 EUR/EQUITY SWITZERLAND REUTERS ))